A Multicenter National Prospective Study of Pregnancy and Neonatal Outcomes in Women With Inflammatory Bowel Disease
Part of paid clinical trials in San Francisco, California.
- Sponsor
- University of California, San Francisco
- Study ID
- NCT00904878
- Status
- Recruiting
Conditions
- Inflammatory Bowel Disease
Eligibility Criteria
- Sex
- FEMALE
- Age
- 18 Years - 45 Years
- Healthy Volunteers
- Not accepted
Study Details
A Multicenter National Prospective Study of Pregnancy and Neonatal Outcomes in Women with Inflammatory Bowel Disease study is being conducted at the University of California San Francisco and 30 other sites around the United States who are part of the CCFA Clinical Alliance. The aim of this study is to determine the effect of medication use and disease activity on the outcome of pregnancy among women with IBD up to 18 years from birth.
Key Dates
- Start date
- Aug 31, 2007
- Status verified
- Jul 2025
- Primary completion
- Jun 30, 2028
- Completion
- Jun 30, 2028
Study Design
- Enrollment
- 1,500 participants (estimated)
Primary Outcome Measure
Determine whether children born to women with IBD have higher rates of developmental delay compared to their age matched non-IBD peers, as measured by the Ages and Stages Questionnaire (ASQ-3) at ages 12, 24, 36, and 48 months [ Time Frame: December 2014 ]
Central Contacts
- Jessica Lim415-885-3734
- Nicole Arima415-514-8947
Locations (2)
| Facility | City | State | ZIP | Site coordinators |
|---|---|---|---|---|
| Please Contact Jessica Lim For Further Information Regarding Other Sites' Locations | San Francisco | California | 94115 | - |
| University of California San Francisco | San Francisco | California | 94115 | Uma Mahadevan, MD (PRINCIPAL_INVESTIGATOR) |
Find similar trials in San Francisco, CA
Related Studies
- The Influence of a Fasting Mimicking Diet on Ulcerative ColitisRecruiting · Stanford University · Palo Alto, California
- Testing an Immunotherapy Anti-cancer Drug, Nivolumab, for Advanced Cancers in Patients With Autoimmune Disorders, AIM-NIVOPHASE1 · Recruiting · National Cancer Institute (NCI) · Birmingham, Alabama
- Effect of Mediterranean Diet in Inflammatory Bowel DiseaseRecruiting · University of California, San Diego · San Diego, California
- Immune Regulation in Ulcerative Colitis or Crohn s DiseaseRecruiting · National Institute of Allergy and Infectious Diseases (NIAID) · Bethesda, Maryland